Advertisement
Advertisement

OPRX

OPRX logo

OptimizeRx Corporation Common Stock

6.65
USD
Sponsored
0.00
0.00%
Jul 16, 16:00 UTC -4
Closed
exchange

Pre-Market

6.66

+0.01
+0.15%

OPRX Earnings Reports

Positive Surprise Ratio

OPRX beat 30 of 37 last estimates.

81%

Next Report

Date of Next Report
Aug 06, 2026
Estimate for Q2 26 (Revenue/ EPS)
$20.61M
/
$0.11
Implied change from Q1 26 (Revenue/ EPS)
+3.85%
/
-21.43%
Implied change from Q2 25 (Revenue/ EPS)
-29.41%
/
-54.17%

OptimizeRx Corporation Common Stock earnings per share and revenue

On May 12, 2026, OPRX reported earnings of 0.14 USD per share (EPS) for Q1 26, beating the estimate of 0.00 USD, resulting in a 4017.65% surprise. Revenue reached 19.84 million, compared to an expected 18.72 million, with a 6.00% difference. The market reacted with a -22.48% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 9 analysts forecast an EPS of 0.11 USD, with revenue projected to reach 20.61 million USD, implying an decrease of -21.43% EPS, and increase of 3.85% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Simulations Plus, Inc.
Report Date
Jul 09, 2026 For Q3 26
Estimate
$0.12
Actual
$0.18
Surprise
+40.73%
FAQ
For Q1 2026, OptimizeRx Corporation Common Stock reported EPS of $0.14, beating estimates by 4017.65%, and revenue of $19.84M, 6% above expectations.
The stock price moved down -22.48%, changed from $6.34 before the earnings release to $4.92 the day after.
The next earning report is scheduled for Aug 06, 2026.
Based on 9 analysts, OptimizeRx Corporation Common Stock is expected to report EPS of $0.11 and revenue of $20.61M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement